Intravenous tranexamic acid administration was associated with significantly improved intraoperative visual clarity and reduced fluid requirements during arthroscopic rotator cuff repair performed in the lateral decubitus position, according to a retrospective cohort study published in BMC Musculoskeletal Disorders. The clinical investigation evaluated 118 surgical patients treated at a single medical institution, comparing those receiving the antifibrinolytic agent to those operated on without any hemostatic drug. Beyond improved visualization scores awarded by the operating surgeons, the retrospective analysis observed notable reductions in total operative duration, estimated blood loss, 24-hour postoperative hemoglobin decline, and resting pain levels among patients in the treatment group.
Arthroscopic rotator cuff repair is a standard procedure for shoulder pathologies, yet intraoperative bleeding frequently impairs visual clarity within the joint space. Poor visualization often prolongs operative time and increases irrigation fluid consumption. While tranexamic acid is used for hemostasis, its efficacy in shoulder arthroscopy remains controversial, especially as a recent randomized controlled trial in the lateral decubitus position found no clear improvement in visual clarity. The researchers designed this retrospective cohort study to describe associations between intravenous tranexamic acid use and intraoperative and early postoperative outcomes, generating hypotheses for future clinical trials.
Participants were divided into two equal cohorts of 59 patients each based on whether intravenous tranexamic acid had been administered at the operating surgeon’s discretion. Patients assigned to the tranexamic acid group received a 1-gram intravenous infusion of tranexamic acid diluted in 100 milliliters of normal saline administered 10 minutes prior to the surgical skin incision. In comparison, patients comprising the control group received no hemostatic agent before or during surgery.
All surgical procedures utilized a gravity-fed irrigation system with a standardized fluid height of 100 centimeters. The primary outcome was intraoperative visual clarity evaluated on a visual analogue scale directly by the operating surgeon, who was not blinded to patient group assignments. Secondary clinical outcomes included total operative time, estimated blood loss, cumulative irrigation fluid volume, 24-hour postoperative hemoglobin concentration drop, 24-hour resting pain assessed on a visual analogue scale, and 30-day complications. Statistical analyses were performed using independent t-tests, chi-square tests, and multivariate linear regression modeling, with no a priori sample size calculation conducted prior to the study.
Patients in the tranexamic acid cohort achieved significantly higher intraoperative visual clarity scores on the visual analogue scale than controls. Surgeons recorded a mean visual clarity score of 8.9 ± 1.1 in the tranexamic acid group compared with 7.3 ± 1.4 in the control group, representing a mean difference of 1.6 points (95% confidence interval: 1.1 to 2.1; P < 0.001). Multivariate linear regression confirmed tranexamic acid use as an independent factor associated with improved visual clarity, showing a regression coefficient beta of 1.56 (P < 0.001).
Surgical efficiency and irrigation demand also differed significantly between the cohorts. Operative time was shorter in the tranexamic acid group, averaging 68.2 ± 12.5 minutes versus 79.7 ± 14.3 minutes in the control group (P < 0.001). Concurrently, irrigation fluid consumption was reduced among tranexamic acid patients, averaging 12.6 ± 1.9 liters compared with 15.4 ± 2.6 liters in controls (P < 0.001).
Measures of blood loss and postoperative recovery similarly favored the tranexamic acid group. Estimated blood loss was lower with tranexamic acid at 15.6 ± 4.8 milliliters compared to 22.4 ± 5.3 milliliters in controls (P < 0.001). The 24-hour postoperative hemoglobin decline was also smaller, averaging 7.2 ± 2.6 grams per liter versus 10.5 ± 3.1 grams per liter in the control group (P < 0.001). Furthermore, resting pain scores at 24 hours were significantly lower with tranexamic acid, averaging 3.2 ± 1.1 compared to 4.5 ± 1.3 for controls (P < 0.001).
Regarding safety, no deep vein thrombosis, pulmonary embolism, or surgical infections occurred in either group during 30 days of follow-up. However, the authors noted that systematic screening for thromboembolism was not performed. The incidence of moderate-to-severe joint swelling was comparable between cohorts, occurring in 5.1 percent of patients in the tranexamic acid group and 8.5 percent in the control group, a difference that was not statistically significant (P = 0.717).
The authors concluded that intravenous tranexamic acid was associated with improved visual clarity, shorter operative duration, reduced blood loss, and lower irrigation volume in lateral-decubitus arthroscopic rotator cuff repair. Nonetheless, given the retrospective, non-randomized design and unblinded surgeon evaluations, these findings represent hypothesis-generating associations rather than evidence of a causal effect. The researchers stated that randomized controlled trials featuring objective, blinded assessments of visualization, standardized anesthetic and surgical protocols, and longer follow-up are needed to verify the results.
Subject of Research: Associations between intravenous tranexamic acid administration and surgical outcomes during arthroscopic rotator cuff repair
Article Title: Intravenous tranexamic acid in arthroscopic rotator cuff repair in the lateral decubitus position: a retrospective cohort study
Article References: Ma, J., Zhu, J., Xie, Y., Qi, W., Li, J., Zhang, F., Wang, S., & Zhang, Q. (2026). Intravenous tranexamic acid in arthroscopic rotator cuff repair in the lateral decubitus position: a retrospective cohort study. BMC Musculoskeletal Disorders. https://doi.org/10.1186/s12891-026-10664-9
Image Credits: AI Generated
DOI: 10.1186/s12891-026-10664-9
Keywords: arthroscopic rotator cuff repair, tranexamic acid, lateral decubitus position, intraoperative visual clarity, retrospective cohort study, operative time, estimated blood loss, irrigation fluid consumption, hemoglobin drop, postoperative resting pain, visual analogue scale, gravity-fed irrigation, hemostatic agents, shoulder arthroscopy, joint swelling, surgical bleeding, thromboembolism screening
News Source: Ophelia Keating. (November 11, 2026). Intravenous Tranexamic Acid Associated With Better Visualization During Rotator Cuff Repair. Scienmag.



